Curative Biotechnology (CUBT) S-1/A IPO registration (amended)

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Curative Biotechnology, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities
	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule			Amount Registered		Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price (1)			Fee Rate			Amount of Registration Fee
Fees to be Paid	Other	Units, each consisting of one share of common stock, par value $0.0001 per share, and one Warrant (4)		457(o)			1,314,285	$	7.00	$	9,199,995		$	0.0000927			853.00
Fees to be Paid	Equity	Shares of common stock, par value $0.0001 per share, included as part of Units (2)		457(g)			1,314,285	$	7.00		(5	)		(5	)		(5	)
Fees to be Paid	Equity	Warrants, included as part of Units		457(g)			1,314,285	$	7.00	$	9,199,995		$	0.0000927			853.00
Fees to be Paid	Equity	Shares of common stock, par value $0.0001 per share, underlying warrants included in the Units (2)		457(o)			1,314,285	$	7.00		(5	)		(5	)		(5	)
Fees to be Paid	Equity	Underwriter’s Warrants (3)		457(g	)		65,713	$	8.75	$	574,989		$	0.0000927			53.30
Fees to be Paid	Equity	Shares of common stock, par value $0.0001 per share, underlying the Underwriter’s Warrants (2)		457(o	)		65,713	$	8.75		(5	)		(5	)		(5	)
		TOTALS								$	18,974,979					$	1,759.30	(6)

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(2) Pursuant to Rule 416 under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(3) Represents Underwriter’ warrants to purchase up to the number of shares of Common Stock equal to 5% of the number of shares of Common Stock underlying Units sold in this offering, including the option to purchase over-allotments at an exercise price equal to 125% of the public offering price per Unit.

(4) Includes 171,428 Units that the underwriters have the option to purchase to cover over-allotments, if any.

(5) No separate registration fee required pursuant to Rule 457(g) under the Securities Act.

(6) Registration fee previously paid in full upon filing of S-1/A filed on August 10, 2022 and September 1, 2022.